- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.63 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.3: 10 residues within 4Å:- Chain A: S.620, S.623, A.624, N.627, Q.729
- Chain B: L.99, H.101, E.265, Y.266, R.343
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.343, B:R.343, B:L.99
- Water bridges: B:H.101, B:R.343, B:L.99
NAG-NAG-BMA-MAN-MAN.15: 10 residues within 4Å:- Chain A: L.99, H.101, E.265, Y.266, R.343
- Chain B: S.620, S.623, A.624, N.627, Q.729
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.343, A:R.343, A:L.99
- Water bridges: A:H.101, A:R.343, A:L.99
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.4: 5 residues within 4Å:- Chain A: S.461, L.462, N.465, P.583, Q.640
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.640, A:Q.640
- Water bridges: A:R.587
NAG-NAG-BMA.16: 5 residues within 4Å:- Chain B: S.461, L.462, N.465, P.583, Q.640
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Q.640, B:Q.640
- Water bridges: B:R.587
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 2 residues within 4Å:- Chain A: N.184, S.186
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.184, A:S.186
NAG.7: 4 residues within 4Å:- Chain A: N.110, T.112, H.113, T.338
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.110
- Water bridges: A:Q.156
NAG.18: 2 residues within 4Å:- Chain B: N.184, S.186
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.184, B:S.186
NAG.19: 4 residues within 4Å:- Chain B: N.110, T.112, H.113, T.338
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.110
- Water bridges: B:Q.156
- 2 x J31: N-{[(1S)-1-carboxy-5-{[2-({4,44-dioxo-48-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-7,10,13,16,19,22,25,28,31,34,37,40-dodecaoxa-3,43-diazaoctatetracont-1-yl}oxy)benzoyl]amino}pentyl]carbamoyl}-L-glutamic acid(Non-covalent)
J31.8: 24 residues within 4Å:- Chain A: F.198, R.199, N.246, D.376, E.413, E.414, G.416, L.417, E.446, R.452, G.507, N.508, R.523, R.525, W.530, N.533, F.535, Y.541, H.542, N.687, K.688, Y.689, A.690
- Ligands: ZN.10
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:W.530, A:F.535, A:Y.689
- Hydrogen bonds: A:N.246, A:N.246, A:G.507, A:G.507, A:G.507, A:N.508, A:Y.541, A:N.687, A:Y.689
- Water bridges: A:N.246, A:E.446, A:R.452, A:R.452, A:R.523, A:K.688
- Salt bridges: A:R.199, A:R.523, A:R.525, A:H.542, A:K.688
J31.20: 24 residues within 4Å:- Chain B: F.198, R.199, N.246, D.376, E.413, E.414, G.416, L.417, E.446, R.452, G.507, N.508, R.523, R.525, W.530, N.533, F.535, Y.541, H.542, N.687, K.688, Y.689, A.690
- Ligands: ZN.22
23 PLIP interactions:23 interactions with chain B- Hydrophobic interactions: B:W.530, B:F.535, B:Y.689
- Hydrogen bonds: B:N.246, B:N.246, B:G.507, B:G.507, B:G.507, B:N.508, B:Y.541, B:N.687, B:Y.689
- Water bridges: B:N.246, B:E.446, B:R.452, B:R.452, B:R.523, B:K.688
- Salt bridges: B:R.199, B:R.523, B:R.525, B:H.542, B:K.688
- 4 x ZN: ZINC ION(Non-covalent)
ZN.9: 6 residues within 4Å:- Chain A: H.366, D.376, E.413, E.414, D.442
- Ligands: ZN.10
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.366, A:D.376, A:D.442, A:D.442, H2O.18
ZN.10: 5 residues within 4Å:- Chain A: D.376, E.414, H.542
- Ligands: J31.8, ZN.9
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.376, A:E.414, A:E.414, A:H.542, H2O.18
ZN.21: 6 residues within 4Å:- Chain B: H.366, D.376, E.413, E.414, D.442
- Ligands: ZN.22
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.366, B:D.376, B:D.442, B:D.442, H2O.42
ZN.22: 5 residues within 4Å:- Chain B: D.376, E.414, H.542
- Ligands: J31.20, ZN.21
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.376, B:E.414, B:E.414, B:H.542, H2O.42
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
CA.12: 4 residues within 4Å:- Chain A: T.258, Y.261, E.422, E.425
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:T.258, A:Y.261, A:E.422, A:E.422, A:E.425
CA.24: 4 residues within 4Å:- Chain B: T.258, Y.261, E.422, E.425
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:T.258, B:Y.261, B:E.422, B:E.422, B:E.425
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tykvart, J. et al., Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-06-18
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.63 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x J31: N-{[(1S)-1-carboxy-5-{[2-({4,44-dioxo-48-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-7,10,13,16,19,22,25,28,31,34,37,40-dodecaoxa-3,43-diazaoctatetracont-1-yl}oxy)benzoyl]amino}pentyl]carbamoyl}-L-glutamic acid(Non-covalent)
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tykvart, J. et al., Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-06-18
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A